Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced that the Company will present its abstract evaluating the impact of ...

What happens when a country at war stops seriously debating its own strategy and goals? In Israel today, that scenario is no ...

Element Solutions Inc ( ESI) Q1 2026 Earnings Call April 29, 2026 8:30 AM EDT Good morning, ladies and gentlemen, and welcome to the Element Solutions Q1 2026 Financial Results Conference Call.

Globally, 68% of consumers said they were interested in trying blended or hybrid foods and beverages, according to ADM’s ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Thank you, Varun, and good morning, everybody. Element Solutions started 2026 strong. The quarter's results are a product of work we've been doing for years in our labs at our sites and alongside our ...

Blends of animal- and plant-derived proteins allow consumers to explore alternative options without abandoning their dietary ...

Bakers have a variety of reasons for replacing eggs in formulations, from price spikes tied to avian flu outbreaks to ...

According to the latest market analysis by Future Market Insights, the global cosmetics ODM market is set for steady expansion, driven by the increasing ...

A paper setting out how finance ministries and other public institutions could think more strategically about emerging ...

Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...